Mathieu Petitjean, Ph.D., is a healthcare executive with 25 years of international experience in Healthcare Diagnostics and Medical Technology. They are President of MedNest and PharmaNest, a role they have held since 2007, and they currently operate Genesis Imaging Services with a focus on the label-free quantification of fibrosis; they have served as CEO of PharmaNest since 2018. MedNest develops the business of innovative Medical Technology Companies for the US markets, exclusively in the convergence space of Drug, Devices and Diagnostics and Healthcare IT, and commercializes IND-Enabling technologies. They are Foreign Trade Adviser of France in the US, founder and President of the French-American Piano Society (since 2014), and a member of several International Medical Societies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices